SAINT ALPHONSUS REGIONAL MEDICAL CENTER
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 1894-01-01
- Employees
- -
- Market Cap
- -
Clinical Trials
2
Active:0
Completed:1
Trial Phases
2 Phases
Phase 2:1
Not Applicable:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Not Applicable
1 (50.0%)Phase 2
1 (50.0%)CardiaMend and Amiodarone for the Prevention of POAF
Not Applicable
Not yet recruiting
- Conditions
- POAFAtrial Fibrillation
- First Posted Date
- 2022-12-08
- Last Posted Date
- 2022-12-08
- Lead Sponsor
- Saint Alphonsus Regional Medical Center
- Target Recruit Count
- 30
- Registration Number
- NCT05641883
Intraarticular Injections of the Hip and Knee With Triamcinolone Versus Ketorolac: A Randomized Controlled Trial
Phase 2
Completed
- Conditions
- Arthritis KneeArthritis of Hip
- Interventions
- First Posted Date
- 2020-06-22
- Last Posted Date
- 2020-06-22
- Lead Sponsor
- Saint Alphonsus Regional Medical Center
- Target Recruit Count
- 120
- Registration Number
- NCT04441112
- Locations
- 🇺🇸
Saint Alphonsus Regional Medical Center, Boise, Idaho, United States
News
No news found